Stay updated with breaking news from V Imaging. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A large case-control study using genetic proxies for PCSK9 inhibitors may help alleviate concerns that the dyslipidemia agents could promote adverse cardiac remodeling and heart failure.
A small molecule produced by the gut microbiome from dietary protein may contribute to development of heart failure and is worth exploring as a possible therapeutic target, researchers say.
Empagliflozin trial data from patients with heart failure with reduced ejection fraction signal more benefit in Black compared with White patients.
These events warrant their own dedicated study, new evidence, and specific guidance, observers say.
A new study comparing cardiac MRI scans in patients before and after having COVID-19 found no new evidence of myocardial injury after infection.